BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1085945)

  • 21. Comparative effects of hycanthone in Schistosoma mansoni and Schistosoma japonicum.
    Hillman GR; Gibler WB; Anderson JB
    Am J Trop Med Hyg; 1977 Mar; 26(2):238-42. PubMed ID: 848646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Observations on the use of hycanthone in a split dosage in the treatment of Schistosomiasis mansoni.
    Rees PH; Roberts JM; Rbook J; Munguti J
    Egypt J Bilharz; 1974; 1(2):203-7. PubMed ID: 4471059
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hycanthone in a single intramuscular dose. Therapeutic results obtained in subjects excreting S. mansoni eggs and treated at Kapolowe (region of the artificial lake of Lufira, Republic of Zaire)].
    Raccurt C; Grimaud JA; Ripert C
    Bull Soc Pathol Exot Filiales; 1974; 67(4):425-35. PubMed ID: 4480532
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum immunoglobulin concentrations in human S. mansoni and S. haematobium infections in the Sudan, with special reference to the effect of chemotherapy.
    Salih SY; Voller A; Woodruff AW
    Tropenmed Parasitol; 1978 Sep; 29(3):269-74. PubMed ID: 726042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hycanthone dose-response in treatment of schistosomiasis mansoni in St. Lucia.
    Cook JA; Jordan P; Armitage P
    Am J Trop Med Hyg; 1976 Jul; 25(4):602-7. PubMed ID: 961979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug therapy of mansoni schistosomiasis].
    Zeitune JM; Ramos SR; Sugmyama LC; Côrte AA
    Arq Gastroenterol; 1980; 17(2):88-95. PubMed ID: 7213141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of a second dose of hycanthone alone and with progesterone caproate on the cure rate and the side reactions of hycanthone in the treatment of S. haematobium infected cases.
    El-Abdin AZ; Samy G; Mousa AH; El-Raziky EH; Roshdy MZ; Abd-El-Rahman H; Hafez S; Adham IA
    Egypt J Bilharz; 1974; 1(1):117-33. PubMed ID: 4619883
    [No Abstract]   [Full Text] [Related]  

  • 28. A study of the mode of action of hycanthone against Schistosoma mansoni in vivo and in vitro.
    Cioli D; Knopf PM
    Am J Trop Med Hyg; 1980 Mar; 29(2):220-6. PubMed ID: 7369442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hycanthone dose-response in Schistosoma mansoni infection in Kenya.
    Warren KS; Siongok TK; Ouma JH; Houser HB
    Lancet; 1978 Feb; 1(8060):352-4. PubMed ID: 75394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of schistosomiasis using hycanthone in 246 children. Side effects, laboratory studies and efficacy of various doses].
    Soares D; Guimarães RX; Domingues SH; de Pádua Vilela M
    AMB Rev Assoc Med Bras; 1975 Mar; 21(3):89-91. PubMed ID: 1079617
    [No Abstract]   [Full Text] [Related]  

  • 31. Control of Schistosoma mansoni transmission by chemotherapy in St. Lucia. I. Results in man.
    Cook JA; Jordan P; Bartholomew RK
    Am J Trop Med Hyg; 1977 Sep; 26(5 Pt 1):887-93. PubMed ID: 907051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical studies on beta-glucuronidase in the urinary bladder of normal and Schistosoma mansoni infected mice treated with hycanthone.
    Saad AA; El-Zoghby SM; Farag HF; el-Sewedy SM; Girgis LH; Moghazy M
    Acta Vitaminol Enzymol; 1977; 31(6):183-6. PubMed ID: 581137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni.
    Haese WH; Bueding E
    J Pharmacol Exp Ther; 1976 Jun; 197(3):703-13. PubMed ID: 180276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An assessment of anti-schistosomal treatment on physical work capacity.
    Awad El Karim MA; Collins KJ; Sukkar MY; Omer AH; Amin MA; Doré C
    J Trop Med Hyg; 1981 Apr; 84(2):67-72. PubMed ID: 7218405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Observations of the treatment of mansoni schistosomiasis with oxamniquine: efficacy in children and in persistent salmonellosis; resistance of a strain of Schistosoma mansoni; hepatic toxicity and neurological side effects.
    Pedro Rde J; de Souza Dias LC; Amato Neto V; de Carvalho SA
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):32-6, 148-52. PubMed ID: 7455507
    [No Abstract]   [Full Text] [Related]  

  • 36. Serology of Schistosoma mansoni infections after chemotherapy.
    Doenhoff MJ; Dunne DW; Lillywhite JE
    Trans R Soc Trop Med Hyg; 1989; 83(2):237-8. PubMed ID: 2514476
    [No Abstract]   [Full Text] [Related]  

  • 37. Hycanthone in experimental schistosomiasis studies on liver pathology in mice treated with one and two doses.
    Farag HF; Guirguis RS; Sherif A; Hanna AT
    J Egypt Med Assoc; 1976; 59(5-6):439-47. PubMed ID: 1032313
    [No Abstract]   [Full Text] [Related]  

  • 38. [Resistance to hycanthone and oxamniquine in patients with a clinical hepato-intestinal form of schistosomiasis].
    Guimarães RX; Tchakerian A; Dias LC; de Almeida FM; Vilela MP; Cabeca M; Takeda AK
    AMB Rev Assoc Med Bras; 1979 Feb; 25(2):48-50. PubMed ID: 314642
    [No Abstract]   [Full Text] [Related]  

  • 39. [Septicemic salmonellosis of long duration. Treatment of intercurrent schistosomiasis mansoni with hycanthone].
    Marinho RP; Neves J
    Rev Inst Med Trop Sao Paulo; 1974 Mar; 16(2):70-6. PubMed ID: 4845453
    [No Abstract]   [Full Text] [Related]  

  • 40. Progress of the control of urinary schistosomiasis among school-children in Iraq by selective mass treatment campaign with etrenol in the last four school years (1973 - 1974 - 1976 - 1977).
    Baquir H
    Bull Endem Dis (Baghdad); 1978 Nov; 19(1-4):77-86. PubMed ID: 757132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.